| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2011.07.002 |
| P698 | PubMed publication ID | 21767593 |
| P50 | author | David K. Shay | Q38641565 |
| Stephanie A. Irving | Q43089463 | ||
| Edward A Belongia | Q59829972 | ||
| Burney A Kieke | Q94540662 | ||
| Jennifer K Meece | Q114338925 | ||
| Mary F. Vandermause | Q121771121 | ||
| P2093 | author name string | Paul Gargiullo | |
| Laura A Coleman | |||
| Stephen Lindstrom | |||
| James G Donahue | |||
| P2860 | cites work | Stochastic processes are key determinants of short-term evolution in influenza a virus | Q21559513 |
| Mapping the antigenic and genetic evolution of influenza virus | Q29617255 | ||
| Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons | Q33541763 | ||
| Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA) | Q33723434 | ||
| Estimability and estimation in case-referent studies | Q34169256 | ||
| The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over | Q34321560 | ||
| Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses | Q34437171 | ||
| Time lines of infection and disease in human influenza: a review of volunteer challenge studies | Q34743132 | ||
| Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines | Q37036552 | ||
| Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines | Q37039271 | ||
| Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza. | Q37136237 | ||
| Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. | Q38377686 | ||
| Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study | Q40342526 | ||
| Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors | Q40362850 | ||
| Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group | Q40625504 | ||
| Comparative efficacy of inactivated and live attenuated influenza vaccines | Q44677378 | ||
| Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
| Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults | Q51152487 | ||
| What Does the Odds Ratio Estimate in a Case-Control Study? | Q57153184 | ||
| Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort | Q57384993 | ||
| Epidemiologic research in an integrated regional medical care system: The Marshfield Epidemiologic Study Area | Q61670412 | ||
| Diarrhea incidence and farm-related risk factors for Escherichia coli O157:H7 and Campylobacter jejuni antibodies among rural children | Q73323418 | ||
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| influenza vaccine | Q383260 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 6558-6563 | |
| P577 | publication date | 2011-07-19 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results | |
| P478 | volume | 29 |
| Q33581365 | A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting |
| Q34271597 | Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial |
| Q35723417 | An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model |
| Q30367464 | Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines? |
| Q60936344 | Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old |
| Q35091073 | Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada |
| Q38819920 | Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review |
| Q30373099 | Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. |
| Q54513872 | Editorial Commentary: Influenza Vaccine Effectiveness: A Glass Both Half Full and Half Empty. |
| Q30391150 | Effect of Statin Use on Influenza Vaccine Effectiveness |
| Q30426206 | Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season |
| Q34451202 | Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies |
| Q30420024 | Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach |
| Q41928095 | Estimated rates of influenza-associated outpatient visits during 2001-2010 in six US integrated health care delivery organizations |
| Q45167252 | Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants |
| Q58722425 | Estimating Vaccine-Driven Selection in Seasonal Influenza |
| Q41637608 | Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors |
| Q30833500 | Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. |
| Q34729188 | Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults |
| Q41499087 | Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial |
| Q34393525 | Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons |
| Q37091628 | Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons |
| Q36115609 | Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine |
| Q30351995 | Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011 |
| Q90246622 | Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease |
| Q28469374 | Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes |
| Q44460142 | Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness |
| Q43416256 | Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness |
| Q38417597 | Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study. |
| Q38798316 | Influenza vaccine effectiveness among high-risk groups: A systematic literature review and meta-analysis of case-control and cohort studies |
| Q42244861 | Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match |
| Q35531934 | Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type |
| Q35743969 | Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013 |
| Q89041842 | Influenza vaccine failure: failure to protect or failure to understand? |
| Q37502676 | Interim estimates of the effectiveness of influenza vaccination against influenza-associated hospitalization in children in Hong Kong, 2015-16 |
| Q42148972 | Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. |
| Q37011575 | Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis |
| Q42253834 | Medically attended respiratory syncytial virus infections in adults aged ≥ 50 years: clinical characteristics and outcomes |
| Q44243917 | Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. |
| Q38907201 | Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies |
| Q41930762 | Perspectives from the society for pediatric research (SPR): Decreased effectiveness of the live attenuated influenza vaccine (LAIV). |
| Q47605953 | Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission. |
| Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
| Q39340731 | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence |
| Q36518793 | Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine |
| Q33905511 | Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults ≥50 years old |
| Q92686229 | Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018 |
| Q34614814 | Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season |
| Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
| Q37260000 | The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings |
| Q51225150 | The case test-negative design for studies of the effectiveness of influenza vaccine. |
| Q100528502 | The challenges of vaccine strain selection |
| Q50208587 | Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season |
| Q40168559 | Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design |
| Q45760952 | Variable definitions of the influenza season and their impact on vaccine effectiveness estimates |
| Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
| Q38420094 | Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season |
Search more.